BioSpace News Archive

In the Largest Study of its Kind, Findings Highlight the Need to Increase Hepatitis C Testing and Treatment to Decrease Rates of Transmission, Morbidity, and Mortality

Imvax, a clinical stage immuno-oncology company driven to transform patient treatment and outcomes with its novel technology platform, announced that John Furey, chief executive officer, will present at the UBS Global Healthcare Virtual Conference

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, today announced that management will participate in a fireside chat at the virtual Morgan Stanley Global Consumer Ingredients Day on Tuesday, May 18 th at 10:45 am ET .

Live video webcast with President and CEO, Walter Klemp, on Monday, May 17, 2021 at 12:30 PM ET

Endologix LLC , a leader in the treatment of vascular disease, today announced the first implant of its ALTO® Abdominal Stent Graft in Canada following recent approval from Health Canada. ALTO was also recently approved for commercial sale in Argentina.

Lengo Therapeutics , a biopharmaceutical company developing novel precision medicines targeting driver mutations in oncology, today announced the appointment of David Johnson as Chairman of its Board of Directors. Mr. Johnson is a biopharmaceutical leader with more than 25 years of experience in drug development and most recently served as Chief Executive Officer (CEO) at VelosBio, a clinical-stage oncology company

Havn Life Sciences Inc., a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, is pleased to announce that it has completed the analytical work under its Health Canada Section 56 exemption.

Concentric Analgesics, Inc. today announced the podium presentation of clinical data for vocacapsaicin, its first-in-class non-opioid lead product candidate for the management of postsurgical pain, at the 46th Annual Regional Anesthesiology and Acute Pain Medicine (ASRA) Meeting on May 13, 2021 in Orlando, Florida.

Initiative Addresses Structural and Cultural Barriers to High-quality, Culturally Competent Health Care for Black and Hispanic Women; Delivers Innovative Health Research, Education and Access Model

Quanterix Corporation (NASDAQ: QTRX), a company helping to transform healthcare with digital protein biomarker technology enabling precision health, today announced it has named Masoud Toloue to the position of President of Quanterix and Diagnostics, effective June 9, 2021.